| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4586077
Max Phase: Preclinical
Molecular Formula: C21H24N2O4
Molecular Weight: 368.43
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COc1cc(O)c(C(=O)/C=C/c2ccc(N3CCNCC3)cc2)c(OC)c1
Standard InChI: InChI=1S/C21H24N2O4/c1-26-17-13-19(25)21(20(14-17)27-2)18(24)8-5-15-3-6-16(7-4-15)23-11-9-22-10-12-23/h3-8,13-14,22,25H,9-12H2,1-2H3/b8-5+
Standard InChI Key: RDBYHAGNGNMHQM-VMPITWQZSA-N
Associated Targets(Human)
ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
MCF7-DOX (137 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 368.43 | Molecular Weight (Monoisotopic): 368.1736 | AlogP: 2.72 | #Rotatable Bonds: 6 |
| Polar Surface Area: 71.03 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 7.18 | CX Basic pKa: 8.89 | CX LogP: 2.43 | CX LogD: 2.32 |
| Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.60 | Np Likeness Score: 0.07 |
References
| 1. Yin H, Dong J, Cai Y, Shi X, Wang H, Liu G, Tang Y, Liu J, Ma L.. (2019) Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance., 180 [PMID:31325783] [10.1016/j.ejmech.2019.05.053] |
Source
Source(1):